Not yet recruiting NCT06820905
Hyperinflammation and Hyperferritinemia in Critically Ill Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Critical Illness, Sepsis, Hyperferritinemia, Hyperinflammatory Syndrome. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Czechia
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Hyperinflammation and Hyperferritinemia in Critically Ill Patients: a Retrospective Observational Single-center Analysis
Overview
Analysing trajectory of critically ill patients with signs of hyperinflammation
Primary outcome measures
- hyperferritinemia [Time frame: 2025]
Secondary outcome measures (4)
- etiology and association of hyperferritinemia [Time frame: 2025]
- mortality a morbidity [Time frame: 2025]
- treatment strategy [Time frame: 2025]
- stratification [Time frame: 2025]
Eligibility criteria
Inclusion criteria
- critically ill patients
- admission between 01.01.2020 and 31.12.2024 (5yrs)
Exclusion criteria
- none
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Czechia · 1 center
- Faculty of Medicine and Teaching Hospital, Charles University — Pilsen
Identifiers
NCT: NCT06820905 · HYFER_2025